Deventer, S. van

patient -10 th-cell disease lactisil -10 treatment e ffector th-cells level group crohn protein lactisil activity cholesterol study il -10 immunosuppression lacti lipid infusion plasma sepsis − 3.5 h change fliximab allogenic ffector gastroenterology allogenic th-cells score trial belgium phospholipid netherland management lipoprotein suppressor th-cells transfer immunosuppression group rhdl infusion suppressor apo a-i phospholipid transfer protein corticosteroids remission pltp activity lipoproteins azathioprine proliferation reference condition endotoxemia phase fl uorescence intensity induction event endotoxin figure reference concentration value university proportion schering bowel allogenic th-cell proliferation / biochimica hdl cholesterol research van deventer response suppressive e ffect administration composition production interleukin antimetabolite correlation methotrexate control condition